Telix Pharmaceuticals (ASX:TLX) signs distribution agreement in Spain

Latest Company News - Finance News Network

English - December 08, 2021 04:13 - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Nickel Mines (ASX:NIC) acquires 70% stake in Oracle nickel project

Next Episode: Stocks of the Hour: Aristocrat Leisure, Telstra & Sydney Airport

08 Dec 2021 - Telix Pharmaceuticals (ASX:TLX) has entered into an exclusive commercial distribution agreement with NUCLIBER for its prostate cancer investigational imaging product Illuccix.